Related Experiment Video

Updated: Aug 11, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

[Therapeutic failure, treatment and non-treatment of childhood epilepsy]

C Garaizar1, J Pérez-García, J Gil-Antón

  • 1Departamento de Pediatría, Hospital de Cruces, Barakaldo, Vizcaya, España.

Revista De Neurologia
|October 17, 1998
PubMed

Insights

In childhood epilepsy, specific syndromes guide treatment. Valproic acid (VPA) and carbamazepine (CBZ) show low failure rates, especially in idiopathic partial epilepsies.

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Background:

  • Epileptic syndrome classification is crucial for prognosis and treatment guidance in childhood epilepsy.
  • Understanding treatment patterns in everyday clinical practice is essential for optimizing care.

Purpose of the Study:

  • To analyze medical therapy patterns based on epileptic syndromes in a hospital-based outpatient neuropediatric clinic.
  • To evaluate treatment outcomes and identify effective antiepileptic drugs for different childhood epilepsy types.

Main Methods:

  • A database survey of 465 epileptic patients treated in 1966 was conducted.
  • An algorithm was used to define therapeutic failure, treatment success, and spontaneous evolution based on syndrome and drug.
  • Data analysis focused on monotherapy, polytherapy, and drug efficacy across various epileptic syndromes.

Main Results:

  • Monotherapy was used in 38% of patients, with 21% achieving therapeutic success and 22% showing spontaneous evolution.
  • Valproic acid (VPA) and carbamazepine (CBZ) demonstrated the lowest failure rates and highest monotherapy percentages.
  • Idiopathic partial epilepsies (85% monotherapy) and idiopathic generalized epilepsies (83% monotherapy) showed favorable outcomes, particularly with VPA.

Conclusions:

  • Database screening and algorithmic analysis provide insights into treatment quality and effectiveness.
  • In idiopathic partial epilepsy, VPA and CBZ are highly effective with low failure rates; treatment may be avoidable in some cases.
  • VPA is the preferred drug for idiopathic generalized epilepsies with a very low failure rate; other syndromes have a ~50% therapeutic failure rate, with VPA offering a slight advantage.
Abstract

More Related Videos

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe06:04

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

Published on: August 16, 2024

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.